The history of folic acid

British Journal of Haematology

Volumn 113, Issue 3, 2001, Pages 579-589

  Hoffbrand, A V ^a   Weir, D G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Folic acid; Homocysteine; Methionine and vitamin B12; Pteroylglutamic acid

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; METHOTREXATE;

ANEMIA; BRAIN DISEASE; DRUG ISOLATION; DRUG METABOLISM; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; FOLIC ACID DEFICIENCY; HEMATOLOGY; HISTORY OF MEDICINE; HUMAN; NEURAL TUBE DEFECT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ANEMIA; BRAIN DISEASES; COLONIC NEOPLASMS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HISTORY, 20TH CENTURY; HUMANS; HYPERHOMOCYSTEINEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; METHOTREXATE; NEURAL TUBE DEFECTS; PORTRAITS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VASCULAR DISEASES; VITAMIN B 12 DEFICIENCY;

EID: 0034986912     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02822.x     Document Type: Review

References (101)

1. Synthetic folic acid therapy in pernicious anemia
2. Synthesis of a compound identical with the L. casei factor isolated from liver
3. Cobalamin-dependent methionine synthase
4. 12 and folic acid
5. On the vitamin Bc conjugate in yeast
6. The biochemistry of folic acid and related pteridines
7. A quantitative assessment of plasma homocysteine as a risk factor from vascular disease. Probable benefits of increasing folic acid intakes
8. Moderate homocysteinaemia: A possible risk factor for arteriosclerotic cerebrovascular disease
9. Folic acid - An innocuous means to reduce plasma homocysteine
10. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland
11. Blood levels of homocysteine and increased risks of cardiovascular disease
12. Hyperhomocysteinemia: An independent risk factor for vascular disease
13. 12 amd serum total homocysteine levels in confirmed Alzheimer's disease
14. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation
15. Folate levels and neural tube defects. Implications for prevention
16. Megaloblastic anaemia of pregnancy and the puerperium
17. Folic acid in treatment of sprue syndrome
18. Failure of nicotinic acid to prevent nutritional cytopenia in the monkey
19. The successful yreatment of vitamin M deficiency in the monkey with highly purified L. casei factor
20. The biological synthesis of 'labile methyl groups'
21. Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroyl-glutamic acid (Aminopterin)
22. Some women pioneers in haematology
23. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
24. Macrocytic anaemia of pregnancy and the puerperium
25. The identification of homocysteine in the urine
26. Multivitamin use, folate, and colon cancer in women in the nurses' health study
27. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
28. Clinical implications of hyperhomo-cysteinaemia
29. Discussion of papers on folic acid read at Nineteenth Annual Meeting of Central Society for Clinical Research
30. Diagnostic criteria and resistance to therapy in the sprue syndrome
31. Homocysteine and vascular disease
32. Folic acid in pernicious anaemia: Failure to prevent neurologic relapse
33. 12 and folic acid metabolism: Folic acid clearance studies
34. The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion
35. Thymidylate concentration in megaloblastic anaemia
36. Anaemia in chicks caused by a vitamin deficiency
37. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
38. Thermolabile methylene tetrahydrofolate reductase in patients with coronary artery disease
39. Efect of deoxyuridine on incorporation of tritiated thymidine: Difference between normoblasts and megaloblasts
40. 12 are independent risk factors for neural tube defects
41. Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine
42. Double-blind randomised controlled trial of folate treatment before conception or recurrence of neural tube defects
43. 12 deficiency on methylfolate metabolism and pteroylpoly-glutamate synthesis in human cells
44. Vascular pathology of homocysteinaemia: Implications for the pathogenesis of arterosclerosis
45. Homocyst(e)inemia in daily practice: Levels in coronary artery disease
46. Homocysteine, diet and cardiovascular diseases: A statement for healthcare professions from the Nutrition Committee
47. Inhibition of pig liver methylenetetrahydrofolate reductase by dihydrofolate: Some mechanistic and regulatory implications
48. Folic acid in the treatment of pernicious anemia
49. Fortification of foods with folic acid - How much is enough
50. The concentration of 'folic acid'
51. The activity of synthetic Lactobacillus carei factor ('folic acid') as an antipernicious anemia substance. I. Observations on four patients, two with Addisonian perivirus anemias, one with nontropical sprue and one with pernicious anemia of pregnancy
52. Serum folate and risk of fatal coronary heart disease
53. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
54. Vascular disease and homocysteine metabolism
55. Homocysteinuria: An enzymatic defect
56. 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria
57. 12, methionine and forminoglutamic acid metabolism
58. Hyperhomocysteinaemia
59. On the peptide nature of vitamin Bc conjugate from yeast (Letter)
60. Fully automated fluorescence assay for determining total homocysteine in plasma
61. 12
62. Lucy Wills (1888-1964): A biographical sketch
63. Homocysteine, vitamins and arterial occlusive disease: An overview
64. Inherited disorders of folate transport and metabolism
65. Role of folic acid/folate in pregnancy: Prevention is better than cure
66. Folate and neural tube defects
67. Association between plasma homocysteine concentrations and extracranial carotid artery disease
68. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism
69. Thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother
70. Purification of anti-pernicious anaemia factor
71. Vitamin deficiencies and neural tube defects
72. Growth factors for bacteria. X. Additional factors required by certain lactic acid bacteria
73. Quantitation of total homocysteine, total cysteine and methionine in normal serum and urine using capillary gas chromatographymass spectrometry
74. Early work with folic acid
75. Evidence of a new growth factor required by chicks
76. Association of demyelination with deficiency of cerebrospinal fluid S-adenosylmethionine in inborn errors of methyl transfer pathway
77. The prevalence of homocysteinaemia and hypercholesterolemia in angiographically defined coronary heart disease
78. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
79. Tropical macrocytic anaemia
80. 12 and folate
81. 6 on progression of subclinical artherosclerosis: A randomised placebo-controlled trial
82. Occurrence of combined system disease in persons with pernicious anemia during treatment with Lactobacillus casei factor ('folic acid')
83. Further studies on folic acid in the treatment of macrocytic anemia
84. Inhibition of glycine N-methyltransferase by folate derivatives: Implications for regulation of methyl group metabolism
85. Nutritional macrocytic anemia. Response to a substance other than the anti-pernicious anemia principle
86. The biochemical basis of the neuropathy in cobalamin deficiency
87. Homocysteine as a risk factor for cardiovascular and related disease: Nutritional implications
88. Colonic mucosal folate concentrations and their association with colorectal cancer
89. Microvascular disease and dementia in the elderly: Are they related to hyperhomocysteinaemia?
90. Homocysteine and artherothrombosis
91. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects
92. Morphology, biology and biochemistry of cobalamin - And folate deficient bone marrow cells
93. Reduced rate of replication fork movement in megaloblastic anemia
94. The pathogenesis of coronary artery disease: A possible role for methionine metabolism
95. Treatment of 'pernicious anaemia of pregnancy' and 'tropical anaemia' with special reference to yeast extract as curative agent
96. Studies in 'pernicious anemia' of pregnancy. I. Preliminary report
97. Studies in 'pernicious anemia' of pregnancy. Part IV. The production of pernicious anemia (Bartonella anemia) in intact albino rats by deficient feeding
98. Tropical macrocytic anaemia: Its relation to pernicious anaemia
99. The production of folic acid by rat liver in vitro